Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avonex Single-Use Autoinjector in Multiple Sclerosis
NCT00828204Phase 3Completed
- Sponsor
- Biogen
- Start
- Jan 2009
- Primary completion
- Jul 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Biogen. Started Jan 2009; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00828204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828204.